Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 2/20 | 0.33 |
| ▸ | FEN1 | P39748 | 2/20 | 0.33 |
| ▸ | CNR2 | P34972 | 14/20 | 0.33 |
| ▸ | CNR1 | P21554 | 5/20 | 0.33 |
| ▸ | PIM1 | P11309 | 2/20 | 0.32 |
| ▸ | FPR2 | P25090 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12836034 | 0.97 | FEN1 (0.34) | ALOX5APFEN1CNR2CNR1PIM1 | |
| SCHEMBL12836492 | 0.97 | FEN1 (0.34) | ALOX5APFEN1CNR2CNR1PIM1 | |
| SCHEMBL12907337 | 0.93 | CNR2 (0.35) | ALOX5APFEN1CNR2CNR1FPR2 | |
| SCHEMBL12222857 | 0.91 | CNR2 (0.34) | ALOX5APFEN1CNR2FPR2 | |
| SCHEMBL11939324 | 0.88 | CNR2 (0.37) | ALOX5APFEN1CNR2CNR1 | |
| SCHEMBL11939352 | 0.88 | CNR2 (0.37) | ALOX5APFEN1CNR2CNR1 | |
| SCHEMBL12836054 | 0.88 | CNR2 (0.36) | ALOX5APFEN1CNR2FPR2 | |
| SCHEMBL12836512 | 0.88 | CNR2 (0.36) | ALOX5APFEN1CNR2FPR2 | |
| SCHEMBL12836499 | 0.88 | FPR2 (0.33) | CNR2PIM1FPR2 | |
| SCHEMBL12836501 | 0.88 | FFAR4 (0.34) | ALOX5APFEN1CNR2FPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110240919-A1 | FIVE-RING COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110240919-A1 | FIVE-RING COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | NCAPD3, CCND3, ZKSCAN2 | ALOX5AP 1073/4885FEN1 3903/4885CNR2 253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.